Utentes

Cancro do Colo do Útero e o Papilomavírus Humano (HPV)



[i] União Europeia com 25 membros mais Islândia, Noruega e Suiça

[ii] 99,7% dos cancros do colo do útero contêm material genético (ADN) do vírus


Referências Bibliográficas

1. Ferlay J, Bray F, Pisani P. et al. Globocan 2002. Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No.5. version 2.0. IARC Press, Lyon 2004

2. Ferlay J, Bray F, Pisani P. et al. Globocan 2000. Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No.5. version 1.0. 2001.

3. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol. Oct 2000;19(1-2):1-5.

4. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. Sep 1999;189(1):12-19.

5. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. May 5 1997;102(5A):3-8.

6. Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev. 1988;10:122-163.

7. Syrjanen K, Hakama M, Saarikoski S, et al. Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. Sex Transm Dis. Jan-Mar 1990;17(1):15-19.

8. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. Jan 13 2003;88(1):63-73.

9. Emerging Infectious Diseases journal of the US Centers of Disease Control (Elbasha E.H. et al., Volume 13, Number 1, January 2007 - http://www.cdc.gov/ncidod/EID/13/1/28.htm).

10. FDA website. http://www.fda.gov/ Accessed 28 February 2007.

11. Medical News website (http://www.medicalnewstoday.com/healthnews.php?newsid=52526 last accessed on 6 March 2007).

12. Medical News website (http://www.medicalnewstoday.com/printerfriendlynews.php?newsid=64007 last accessed on 2 March 2007).

13. NCI website. http://www.nci.nih.gov.

14. Khuder SA. Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer. Feb-Mar 2001;31(2-3):139-148.

15. Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. Dec 3 2003;95(23):1772-1783.

16. Sonnex C, Strauss S, Gray JJ. Detection of human papillomavirus DNA on the fingers of patients with genital warts. Sex Transm Infect. Oct 1999;75(5):317-319.

17. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. Feb 1 2003;157(3):218-226.

18. PHLS. CDR Weekly 2001; 11(35).

19. Jacobs MV, Walboomers JM, Snijders PJ, et al. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer. Jul 15 2000;87(2):221-227.

20. Wieland U, Pfister H. Papillomaviruses in human pathology: Epidemiology, pathogenesis and oncologic role. In: Gross, Barasso Eds. Human papilloma virus infection: A clinical atlas. Ullstein Mosby 1997. p1–8.

21. Pagliusi SR, Teresa Aguado M. Efficacy and other milestones for human papillomavirus vaccine introduction. Vaccine. Dec 16 2004;23(5):569-578.

22. Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev. May 2005;14(5):1157-1164.

23. Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer. Jul 7 2003;89(1):101-105.

24. National Cancer Institute website. . http://www.cancer.gov. Accessed 26 February, 2007.

25. Goldie SJ, Kohli M, Grima D, et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst. Apr 21 2004;96(8):604-615.

26. Stanley M. Immune responses to human papillomavirus. Vaccine. Mar 30 2006;24 Suppl 1:S16-22.

27. http://www.son.wisc.edu/ce/programs/asynch/bccb/cervical1/4-2-riskfactors.html. Last accessed 5 May 2006.

28. http://www.cancer.gov/cancertopics/pdq/screening/cervical/ healthprofessional. Last accessed 5 May 2006.

29. McCrory et al. Evaluation of cervical cytology: Evidence report/technology assessment No. 5. (Prepared by Duke University under contract No. 290-97-0014.) AHCPR Publication No. 99-E010. Rockville, MD: Agency for Health Care Policy and Research. February 1999.

30. NHS Cervical Screening Annual Review 2005. (www.cancerscreening.nhs.uk/cervical/publication/cervical-annual-review-2005.pdf).

31. IARC Handbook of Cancer Prevention. Cervix cancer screening. Volume 10. p163–199. IARC Press, 2005. Lyon, France.

32. http://www.fda.gov/womens/getthefacts/paptests.html Accessed 26 February 2007.









Nota: Os Médicos têm que fazer login para pesquisar informação restrita.